Literature DB >> 17132966

3D mapping of mini-mental state examination performance in clinical and preclinical Alzheimer disease.

Liana G Apostolova1, Po H Lu, Steve Rogers, Rebecca A Dutton, Kiralee M Hayashi, Arthur W Toga, Jeffrey L Cummings, Paul M Thompson.   

Abstract

The Mini-mental State Examination (MMSE) is a brief cognitive screening instrument frequently used to track Alzheimer disease (AD) progression. We investigated the structural neuroimaging correlates of MMSE performance in patients with clinical and preclinical AD. We analyzed structural magnetic resonance imaging data from 29 probable AD and 5 MCI patients who later converted to probable AD using an advanced 3D cortical mapping technique. MMSE scores were entered as covariates in a general linear model that predicted the gray matter density at each cortical surface point. The results were corrected for multiple comparisons by permutation testing. The global permutation-corrected significance for the maps linking gray matter loss and cognitive decline was P=0.005 for the left and P=0.012 for the right hemisphere. Strongest correlations between MMSE score and gray matter integrity were seen in the entorhinal, parahippocampal, precuneus, superior parietal, and subgenual cingulate/orbitofrontal cortices. Significant correlations were also seen bilaterally in the temporal, the middle frontal and the left angular and supramarginal gyri. As a global cognitive measure, MMSE depends on the integrity of widely distributed cortical areas in both brain hemispheres with left-sided predominance.

Entities:  

Mesh:

Year:  2006        PMID: 17132966     DOI: 10.1097/01.wad.0000213857.89613.10

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  23 in total

Review 1.  Brain mapping as a tool to study neurodegeneration.

Authors:  Liana G Apostolova; Paul M Thompson
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 2.  The clinical use of structural MRI in Alzheimer disease.

Authors:  Giovanni B Frisoni; Nick C Fox; Clifford R Jack; Philip Scheltens; Paul M Thompson
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

Review 3.  Staging Alzheimer's disease progression with multimodality neuroimaging.

Authors:  Michael Ewers; Giovanni B Frisoni; Stefan J Teipel; Lea T Grinberg; Edson Amaro; Helmut Heinsen; Paul M Thompson; Harald Hampel
Journal:  Prog Neurobiol       Date:  2011-06-22       Impact factor: 11.685

4.  Initial mini-mental state and cerebral perfusion in Alzheimer's disease.

Authors:  T Ones; I Midi; F Dede; N Tuncer; T Y Erdil; O Onultan; S Ceylan; S Inanir; H T Turoglu
Journal:  Clin Neuroradiol       Date:  2012-01-03       Impact factor: 3.649

5.  Validation and diagnostic accuracy of predictive curves for age-associated longitudinal cognitive decline in older adults.

Authors:  Patrick J Bernier; Christian Gourdeau; Pierre-Hugues Carmichael; Jean-Pierre Beauchemin; René Verreault; Rémi W Bouchard; Edeltraut Kröger; Robert Laforce
Journal:  CMAJ       Date:  2017-12-04       Impact factor: 8.262

6.  Cortical thickness and semantic fluency in Alzheimer's disease and mild cognitive impairment.

Authors:  Jennifer A Eastman; Kristy S Hwang; Andreas Lazaris; Nicole Chow; Leslie Ramirez; Sona Babakchanian; Ellen Woo; Paul M Thompson; Liana G Apostolova
Journal:  Am J Alzheimers Dis (Columbia)       Date:  2013

7.  Surface-based analysis on shape and fractional anisotropy of white matter tracts in Alzheimer's disease.

Authors:  Anqi Qiu; Kenichi Oishi; Michael I Miller; Constantine G Lyketsos; Susumu Mori; Marilyn Albert
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

8.  Predicting clinical scores from magnetic resonance scans in Alzheimer's disease.

Authors:  Cynthia M Stonnington; Carlton Chu; Stefan Klöppel; Clifford R Jack; John Ashburner; Richard S J Frackowiak
Journal:  Neuroimage       Date:  2010-03-25       Impact factor: 6.556

9.  Glia maturation factor expression in entorhinal cortex of Alzheimer's disease brain.

Authors:  Ramasamy Thangavel; Duraisamy Kempuraj; Deirdre Stolmeier; Poojya Anantharam; Mohammad Khan; Asgar Zaheer
Journal:  Neurochem Res       Date:  2013-05-29       Impact factor: 3.996

10.  3D mapping of language networks in clinical and pre-clinical Alzheimer's disease.

Authors:  Liana G Apostolova; Po Lu; Steve Rogers; Rebecca A Dutton; Kiralee M Hayashi; Arthur W Toga; Jeffrey L Cummings; Paul M Thompson
Journal:  Brain Lang       Date:  2007-05-07       Impact factor: 2.381

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.